Showing 6 posts of 6 posts found.


GSK receives FDA Fast Track designation for novel gonorrhoea vaccine

June 27, 2023
Research and Development FDA, GSK, Infections and infestations, Vaccine, fast track designation, gonorrhoea

GSK has announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for its investigational vaccine …


FDA approves new tests for chlamydia and gonorrhoea

May 24, 2019
Medical Communications STIs, chlamydia, gonorrhoea, public health FDA

The FDA has approved two new tests which make it easier to diagnose common STIs. The approval comes after a …


Investigational antibiotic shows high cure rates in gonorrhoea at Phase 2

November 8, 2018
Research and Development National Institute of Allergy and Infectious Diseases, National Institutes of Health, gonorrhoea, pharma, zoliflodacin

A Phase 2 study sponsored by The National Institute of Allergy and Infectious Diseases (NIAID), a branch of the National …


Gonorrhoea is just the tip of the antimicrobial resistance iceberg

October 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NovaBiotics, biotech, drugs, gonorrhoea, pharma, pharmaceutical

Dr Deborah O’Neil, Chief Executive and Scientific Officer at NovaBiotics, discusses the WHO-recognised threat of ‘super gonorrhoea’ and the antimicrobial …


Hope in quest for gonorrhoea vaccination

July 11, 2017
Manufacturing and Production, Research and Development WHO, gonorrhoea, meningitis, vaccination

Only last week, the WHO expressed serious concerns about the possibility of strains of gonorrhoea developing that could be resistant …


Oral sex creating super-gonorrhoea

July 7, 2017
Research and Development antibiotic resistance, gonorrhoea

The WHO has announced that data from across 77 different countries show that the sexually-transmitted infection (STI) gonorrhoea is becoming …

Latest content